← Back

Wire · operational-macro

FDA Approves Weekly Insulin for Pediatric Type 2 Diabetes

Published

20 November 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at jamanetwork.com →

◆ Verified

Fusion42 · 20 November 2026 · Fusion42 review

The FDA approved once-weekly insulin icodec-abae (Awiqli) for pediatric patients aged 10 and above with type 2 diabetes, providing an alternative to daily basal insulin injections with a safety profile consistent with existing insulin products.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

This FDA approval opens the door for you to pitch a weekly insulin product as a simpler paediatric diabetes treatment, challenging daily insulin makers and shifting patient adherence expectations.

◆ Coverage

1 source · 20 Nov 2026

◆ Related on Wire

◆ Topics

Medtechinsulinpediatricstype-2-diabetesfda-approvalweekly-injection